# The Prevalence, Risk Factors and Optimal Biopsy Protocol of BE

> **NCT05818072** · NA · RECRUITING · sponsor: **E-DA Hospital** · enrollment: 165 (estimated)

## Conditions studied

- Barrett's Esophagus
- Intestinal Metaplasia

## Interventions

- **PROCEDURE:** One biopsy
- **PROCEDURE:** Three biopsy
- **PROCEDURE:** Seattle protocol
- **DEVICE:** Endoscopy

## Key facts

- **NCT ID:** NCT05818072
- **Lead sponsor:** E-DA Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-13
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 165 (ESTIMATED)
- **Last updated:** 2023-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05818072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05818072, "The Prevalence, Risk Factors and Optimal Biopsy Protocol of BE". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05818072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*